# Clustering Approach 2 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.566265934178693	Range of duration = 0.07 to 177.04, nDeath = 13, nCensor = 59
2	AGE	ANOVA	0.0777915184689116	Range of values = 21 to 80, Mean = 48.8219, StdDev = 13.3826, nMissing = 1
3	PATHOLOGY.T.STAGE	Chi-square test	0.687704974875009	nTypes = 2 (T1/T2+T3+T4), nPatients = 46/24, nMissing = 4
4	PATHOLOGY.N.STAGE	Chi-square test	0.860299426403226	nTypes = 2 (0/1), nPatients = 45/24, nMissing = 5
5	PATHOLOGY.M.STAGE	Chi-square test	0.0322297522538014	nTypes = 3 (M0/M1/MX), nPatients = 46/2/21, nMissing = 5
6	HISTOLOGICAL.TYPE	Chi-square test	7.36122893077818e-05	nTypes = 4 (CERVICAL SQUAMOUS CELL CARCINOMA/ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE/ENDOCERVICAL TYPE OF ADENOCARCINOMA/ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX), nPatients = 64/1/8/1
7	RADIATIONS.RADIATION.REGIMENINDICATION	Chi-square test	0.352987641689688	nTypes = 2 (NO/YES), nPatients = 18/56
8	NUMBERPACKYEARSSMOKED	ANOVA	0.959713173364787	Range of values = 2.5 to 50, Mean = 19.2368, StdDev = 12.7806, nMissing = 55
9	NUMBER.OF.LYMPH.NODES	ANOVA	0.786837595066966	Range of values = 0 to 16, Mean = 1.03175, StdDev = 2.48199, nMissing = 11
